Dermata Therapeutics, Inc.

DRMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-K Feb 21, 2023 FORM 10-K
8-K Feb 8, 2023 FORM 8-K
SC 13D/A Jan 18, 2023 SC 13D/A
DEF 14A Jan 13, 2023 DEF 14A
4 Jan 5, 2023 FORM 4
4 Jan 5, 2023 PRIMARY DOCUMENT
4 Jan 5, 2023 PRIMARY DOCUMENT
PRE 14A Jan 3, 2023 PRE 14A
RW Dec 29, 2022 RW
8-K Dec 15, 2022 FORM 8-K
8-K Dec 5, 2022 FORM 8-K
EFFECT Nov 25, 2022
CORRESP Nov 22, 2022
UPLOAD Nov 22, 2022
S-3 Nov 15, 2022 FORM S-3
8-K Nov 10, 2022 FORM 8-K
10-Q Nov 10, 2022 FORM 10-Q
4 Oct 7, 2022 PRIMARY DOCUMENT
4 Oct 7, 2022 PRIMARY DOCUMENT
4 Oct 7, 2022 PRIMARY DOCUMENT
4 Oct 7, 2022 PRIMARY DOCUMENT
4 Oct 7, 2022 PRIMARY DOCUMENT
4 Oct 7, 2022 PRIMARY DOCUMENT
8-K Sep 23, 2022 FORM 8-K
S-8 Aug 26, 2022 FORM S-8
← Newer Page 10 of 15 · 366 filings Older →